Darin Lippoldt Neurocrine Biosciences Inc (NBIX) insider trading activity

Darin Lippoldt is Chief Legal Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 43,405 shares of NBIX, which is worth approximately $4.8 Million. The most recent transaction as insider was on Jan 31, 2023, when has been sold 1,250 shares (Common Stock) at a price of $109.97 per share, resulting in proceeds of $137,462. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.4K

9.22% 3M change

9.22% 12M change

Total Value Held $4.8 Million

Darin Lippoldt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2023	SELL Open market or private sale	$137,462 $109.97 p/Share	1,250 Reduced 3.95%	30,357 Common Stock
Nov 08 2022	SELL Open market or private sale	$635,453 $125.04 p/Share	5,082 Reduced 14.81%	29,234 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	$219,745 $43.24 p/Share	5,082 Added 12.9%	34,316 Common Stock
Nov 03 2022	SELL Open market or private sale	$564,840 $125.02 p/Share	4,518 Reduced 13.39%	29,234 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$195,358 $43.24 p/Share	4,518 Added 11.81%	33,752 Common Stock
Nov 02 2022	SELL Open market or private sale	$50,000 $125.0 p/Share	400 Reduced 1.35%	29,234 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$17,296 $43.24 p/Share	400 Added 1.33%	29,634 Common Stock
Nov 01 2022	SELL Open market or private sale	$1,200,900 $120.09 p/Share	10,000 Reduced 25.49%	29,234 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$432,400 $43.24 p/Share	10,000 Added 20.31%	39,234 Common Stock
Oct 27 2022	SELL Open market or private sale	$566,342 $115.04 p/Share	4,923 Reduced 14.41%	29,234 Common Stock
Oct 27 2022	BUY Exercise of conversion of derivative security	$212,871 $43.24 p/Share	4,923 Added 12.6%	34,157 Common Stock
Oct 26 2022	SELL Open market or private sale	$583,957 $115.02 p/Share	5,077 Reduced 14.8%	29,234 Common Stock
Oct 26 2022	BUY Exercise of conversion of derivative security	$219,529 $43.24 p/Share	5,077 Added 12.89%	34,311 Common Stock
Oct 04 2022	SELL Open market or private sale	$1,110,400 $111.04 p/Share	10,000 Reduced 25.49%	29,234 Common Stock
Oct 04 2022	BUY Exercise of conversion of derivative security	$432,400 $43.24 p/Share	10,000 Added 20.31%	39,234 Common Stock
Sep 08 2022	SELL Bona fide gift	-	100 Reduced 0.34%	29,234 Common Stock
Sep 07 2022	SELL Bona fide gift	-	100 Reduced 0.34%	29,334 Common Stock
Mar 22 2022	SELL Open market or private sale	$803,648 $95.05 p/Share	8,455 Reduced 22.34%	29,396 Common Stock
Mar 18 2022	SELL Open market or private sale	$28,500 $95.0 p/Share	300 Reduced 0.79%	37,851 Common Stock
Feb 08 2022	SELL Open market or private sale	$72,434 $79.51 p/Share	911 Reduced 2.33%	38,112 Common Stock
Feb 07 2022	SELL Open market or private sale	$255,626 $80.69 p/Share	3,168 Reduced 7.83%	37,296 Common Stock
Dec 10 2021	SELL Bona fide gift	-	120 Reduced 0.35%	34,448 Common Stock
Feb 09 2021	SELL Open market or private sale	$4,221,668 $116.64 p/Share	36,194 Reduced 51.3%	34,361 Common Stock
Feb 09 2021	BUY Exercise of conversion of derivative security	$1,302,622 $35.99 p/Share	36,194 Added 47.27%	40,369 Common Stock
Feb 08 2021	SELL Open market or private sale	$397,665 $116.72 p/Share	3,407 Reduced 9.02%	34,361 Common Stock

Darin Lippoldt

Chief Legal Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account